ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,975 | +7.9% | 34 | 0.0% | 0.00% | – |
Q2 2023 | $1,831 | +35.5% | 34 | 0.0% | 0.00% | – |
Q1 2023 | $1,351 | -1.2% | 34 | 0.0% | 0.00% | – |
Q4 2022 | $1,368 | +36.8% | 34 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 34 | -35.8% | 0.00% | – |
Q4 2021 | $2,000 | -60.0% | 53 | -65.8% | 0.00% | -100.0% |
Q2 2021 | $5,000 | +400.0% | 155 | +453.6% | 0.00% | – |
Q3 2020 | $1,000 | – | 28 | +115.4% | 0.00% | – |
Q2 2020 | $0 | – | 13 | +62.5% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 8 | -27.3% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | – | 11 | +83.3% | 0.00% | – |
Q1 2019 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 6 | -62.5% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | – | 16 | +166.7% | 0.00% | – |
Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 6 | +50.0% | 0.00% | – |
Q4 2016 | $0 | – | 4 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |